Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.8452
+0.0351 (4.33%)
At close: Aug 1, 2025, 4:00 PM
0.8385
-0.0067 (-0.79%)
After-hours: Aug 1, 2025, 7:59 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $3.67 million as of August 1, 2025. Its market cap has increased by 26.32% in one year.
Market Cap
3.67M
Enterprise Value
61.27K
1-Year Change
26.32%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $3.67M, a decrease of -98.23%. That is a compound annual growth rate of -73.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.67M | -62.44% |
| Dec 31, 2024 | 9.77M | 269.37% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.19B |
| Johnson & Johnson | 396.94B |
| AbbVie | 334.12B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 228.82B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.86B |
| Novo Nordisk | 213.92B |